Mayne Pharma reported AUD94.83M in Gross Profit on Sales for its first fiscal semester of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Ansell ANN:AU USD 340.4M 15M
Cochlear COH:AU AUD 632.6M 14.8M
CSL CSL:AU USD 2.28B 1.16B
Ecofibre Ltd EOF:AU AUD 8.04M 446K
Healius Ltd HLS:AU AUD 854.8M 309.9M
Integral Diagnostics Ltd IDX:AU AUD 169.48M 2.76M
Medical Developments International Ltd MVP:AU AUD 5.63M 3.73M
Nanosonics Ltd NAN:AU AUD 45.5M 901K
Next Science Ltd NXS:AU USD 4.38M 515.78K
Polynovo Ltd PNV:AU AUD 22.01M 4.78M
Probiotec Ltd PBP:AU AUD 30.62M 4M
Ramsay Health Care RHC:AU AUD 4.91B 229.8M
ResMed RMD:AU USD 522.51M 31.31M
Sigma Healthcare Ltd SIG:AU AUD 181.95M 10.71M
Sonic Healthcare SHL:AU AUD 3.79B 155.43M
Telix Pharmaceuticals Ltd TLX:AU AUD 13.48M 10.47M